Gilead Sciences Bucks Trend In Biotech Short Interest

By: via Benzinga
While Gilead Sciences, Inc. (NASDAQ: GILD) stood out among the leading biotechs and emerging pharmaceuticals as the only one that saw ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.